Invention Grant
- Patent Title: Reducing junction epitope presentation for neoantigens
-
Application No.: US16766627Application Date: 2018-11-21
-
Publication No.: US11885815B2Publication Date: 2024-01-30
- Inventor: Brendan Bulik-Sullivan , Thomas Francis Boucher , Roman Yelensky , Jennifer Busby
- Applicant: Gritstone bio, Inc.
- Applicant Address: US CA Emeryville
- Assignee: Gritstone bio, Inc.
- Current Assignee: Gritstone bio, Inc.
- Current Assignee Address: US CA Emeryville
- Agency: Goodwin Procter LLP
- International Application: PCT/US2018/062294 2018.11.21
- International Announcement: WO2019/104203A 2019.05.31
- Date entered country: 2020-05-22
- Main IPC: G01N33/68
- IPC: G01N33/68 ; G16B40/00 ; G16B30/00 ; C40B30/04 ; G01N33/574

Abstract:
Given a set of therapeutic epitopes, a cassette sequence is designed to reduce the likelihood that junction epitopes are presented in the patient. The cassette sequence is designed by taking into account presentation of junction epitopes that span the junction between a pair of therapeutic epitopes in the cassette. The cassette sequence may be designed based on a set of distance metrics each associated with a junction of the cassette. The distance metric may specify a likelihood that one or more of the junction epitopes spanning between a pair of adjacent epitopes will be presented.
Public/Granted literature
- US20210011026A1 REDUCING JUNCTION EPITOPE PRESENTATION FOR NEOANTIGENS Public/Granted day:2021-01-14
Information query
IPC分类: